Dib Nabil, Poirier Nancy, Samuel Michelle, Hermann Honfo Sewanou, Zaidi Ali, Opotowsky Alexander R, Mongeon François-Pierre, Mondésert Blandine, Kay Joseph, Ibrahim Reda, Hamilton Robert M, Fournier Anne, Jameson Susan M, Dore Annie, Cook Stephen, Cohen Scott, Chaix Marie-A, Broberg Craig S, Aboulhosn Jamil, Khairy Paul
Montreal Heart Institute, Université de Montréal Quebec Canada.
Nationwide Children's Hospital, Ohio State University Columbus OH.
J Am Heart Assoc. 2024 Dec 3;13(23):e034757. doi: 10.1161/JAHA.124.034757. Epub 2024 Nov 27.
The univentricular heart with a predominant right ventricle morphology (uRV) has been associated with a higher rate of adverse cardiovascular events. It remains to be determined whether the specific type of uRV influences outcomes.
A North American multicenter retrospective cohort study was conducted by the Alliance for Adult Research in Congenital Cardiology on individuals with a uRV and total cavopulmonary connection Fontan. The incidence of a composite outcome consisting of all-cause mortality, cardiac transplantation, atrial arrhythmias, or thromboembolic events was compared among patients with Fontan palliation who had hypoplastic left heart syndrome (HLHS) versus other forms of uRV (non-HLHS). All components of the composite outcome were classified by a blinded adjudicating committee. Competing risks were taken into account in time-to-event analyses. A total of 171 patients with uRV of whom 76 (44.4%) had HLHS were followed for 10.2±5.7 years. The composite outcome occurred in 7.1 versus 2.1 cases per 100 person-years in patients with HLHS versus non-HLHS (<0.0001). In multivariable analyses, HLHS was associated with a significantly higher risk of the composite outcome (hazard ratio [HR], 6.13 [95% CI, 2.92-12.69], <0.001). Moreover, HLHS was associated with significantly higher rates of all components of the primary outcome.
Among patients with a uRV and Fontan palliation, HLHS is associated with a significantly higher rate of adverse cardiovascular events.
右心室为主型单心室心脏(uRV)与较高的不良心血管事件发生率相关。uRV的具体类型是否会影响预后仍有待确定。
先天性心脏病成人研究联盟在北美进行了一项多中心回顾性队列研究,研究对象为患有uRV和全腔静脉肺动脉连接Fontan手术的个体。比较了接受Fontan姑息治疗的左心发育不全综合征(HLHS)患者与其他形式uRV(非HLHS)患者中由全因死亡率、心脏移植、房性心律失常或血栓栓塞事件组成的复合结局的发生率。复合结局的所有组成部分均由一个盲法判定委员会进行分类。在事件发生时间分析中考虑了竞争风险。共有171例uRV患者,其中76例(44.4%)患有HLHS,随访时间为10.2±5.7年。HLHS患者和非HLHS患者的复合结局发生率分别为每100人年7.1例和2.1例(<0.0001)。在多变量分析中,HLHS与复合结局的风险显著升高相关(风险比[HR],6.13[95%CI,2.92 - 12.69],<0.001)。此外,HLHS与主要结局的所有组成部分的发生率显著升高相关。
在接受Fontan姑息治疗的uRV患者中,HLHS与显著更高的不良心血管事件发生率相关。